Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Total Debt Growth (1y) (2010 - 2026)

Analysis

Edwards Lifesciences (EW) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 142.67%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -1.59%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -9.88%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 8.95%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 0.12%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -9.07%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 12.29%
10 Zimmer Biomet Holdings 18.70 Bn 18.30 Bn 1.54 Bn -1.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.12%
Mar 31, 2026 0.12%
Dec 31, 2025 0.10%
Sep 30, 2025 0.12%
Jun 30, 2025 0.12%
Mar 31, 2025 0.10%
Dec 31, 2024 0.12%
Sep 30, 2024 0.12%
Jun 30, 2024 0.10%
Mar 31, 2024 0.12%
Dec 31, 2023 0.12%
Sep 30, 2023 0.10%
Jun 30, 2023 0.12%
Mar 31, 2023 0.10%
Dec 31, 2022 0.10%
Sep 30, 2022 0.12%
Jun 30, 2022 0.10%
Mar 31, 2022 0.12%
Dec 31, 2021 0.12%
Sep 30, 2021 0.10%